The possible preliminary out of vaccinations with the active ingredient from Johnson & Johnson (J&J) in the USA weighed on the Dow Jones Industrial on Tuesday. In early trading, it was down 0.39 percent to 33,615 points. In the US leading index, the shares of Johnson & Johnson were among the biggest losers with minus two percent. The technology-heavy Nasdaq exchange, on the other hand, set new records.
